GBM with the O6-methylguanine-DNA-methyltransferase (MGMT) gene promoter methylation status is sensitive to temozolomide (TMZ) chemotherapy; however, recurrence is inevitable, and is perhaps due to the existence of GSCs, which when present display only partial uptake of TMZ. The gene discussed is MGMT; the disease is glioblastoma.